Summary of surgical data of all 36 study patients underdoing penetrating keratoplasty
| hEGF (100 μg/ml) (n=9) | Placebo (n=9) | hEGF (30 μg/ml) (n=9) | Placebo (n=9) | |
|---|---|---|---|---|
| Donor size (mm) (mean (SD)) | 7.75 (0.25) | 7.75 (0.25) | 7.67 (0.25) | 7.78 (0.26) |
| Bed size (mm) (mean (SD)) | 7.44 (0.17) | 7.44 (0.17) | 7.93 (0.22) | 7.50 (0.25) |
| ECCE | 3 | 3 | 1 | 1 |
| IOL removed | 1 | 1 | 0 | 1 |
| IOL implant | 4 | 4 | 1 | 2 |
| PC | 3 | 3 | 1 | 1 |
| Iris | 1 | 1 | 0 | 1 |
| Vitrectomy | 1 | 1 | 2 | 1 |
| Complications | 1 | 0 | 0 | 0 |
ECCE = extracapsular cataract extraction; IOL = intraocular lens; PC = posterior chamber lens; Iris = iris fixated lobster claw lens.